Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.
Press releases published on April 24, 2025

CoreCard Corporation Schedules First Quarter 2025 Earnings Release and Conference Call
NORCROSS, Ga., April 24, 2025 (GLOBE NEWSWIRE) -- CoreCard Corporation (NYSE: CCRD), the leading provider of innovative credit technology solutions and processing services to the financial technology and services market, intends to hold an investor …

BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™
(IMAGES BELOW) Complete resolution of lung metastasis confirmed at 4 month follow-up in hormone receptor positive (HR+) breast cancer patient Treatment well-tolerated and patient remains on study with stable disease elsewhere Sustained clinical response …

Kura Oncology to Report First Quarter 2025 Financial Results
SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced it will …

Ace Vision Group Announces Initial Close of $29.4 Million Series B Financing Round
Funding supports the commercial product development of VisioLite® Device and Laser Scleral Microporation Human Clinical Study. Capital raised to date provides strong financial position to prepare the device for regulatory trials and submissions. BOSTON, …

Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-251 in Duchenne Muscular Dystrophy
- Recently presented data demonstrated sustained functional improvement with DYNE-251 treatment through 18 months - - Data from the fully enrolled DELIVER registrational expansion cohort is planned for late 2025 - WALTHAM, Mass., April 24, 2025 (GLOBE …

Avidicure Launches with $50 Million in Seed Financing to Develop New Multifunctional Antibody Modality to Treat Cancer
AVC-Boosters are designed as dual agonistic antibodies to safely deliver targeted and potent monotherapy with broad application in oncology Lead product AVC-S-101 is a TROP2-targeting booster being developed for non-small cell lung cancer and multiple …

TruGolf Improves Balance Sheet with Agreement to Eliminate All Convertible Notes
All Convertible Notes …

Diginex and Baker Tilly Singapore Announce Strategic Alliance to Deliver diginexESG Platform to Baker Tilly ’s Clients
LONDON, April 24, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex”) (NASDAQ: DGNX), a leading impact technology company specializing in environmental, social, and governance (ESG) solutions, and Baker Tilly Singapore (“Baker Tilly”), a globally …

Pasithea Therapeutics to Present Updated Data from Ongoing Phase 1 Trial of PAS-004 in Advanced Cancer Patients at the 2025 ASCO Annual Meeting
MIAMI, April 24, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of …

Ligand to Report First Quarter 2025 Financial Results on May 8, 2025
JUPITER, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report first quarter 2025 financial results before the opening of the U.S. financial markets on Thursday, May 8, 2025. The …

Axonius Appoints Robert Skinner (USAF Retired) to Axonius Federal Systems Board
RESTON, Va., April 24, 2025 (GLOBE NEWSWIRE) -- Axonius, the leader in cyber asset management that delivers visibility and actionability across all digital assets, today announced the appointment of (USAF Ret.) Robert Skinner to the Axonius Federal Systems …

Kymera Therapeutics to Unveil New Oral Immunology Program and Report First Quarter 2025 Financial Results on May 9, 2025
Watertown, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that it …

PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
SAN JOSE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited …

Terrapin Beer Co. Celebrates 23 Years of Craft Beer and Environmental Stewardship with Terraprint Initiative and Orvis Partnership
ATHENS, Ga., April 24, 2025 (GLOBE NEWSWIRE) -- Terrapin Beer, a leading craft brewery known for its innovative and high-quality beers and a Tilray Brands, Inc., craft beer brand (NASDAQ: TLRY and TSX: TLRY), is thrilled to partner with Orvis, the renowned …

YXT.com Filed 2024 Annual Report on Form 20-F
SUZHOU, China, April 24, 2025 (GLOBE NEWSWIRE) -- YXT.com Group Holding Limited (NASDAQ: YXT) (“YXT.com” or the “Company”), a provider of AI-enabled enterprise productivity solutions, today announced that it has filed its annual report on Form 20-F for the …

Towards the Light: Co-creating a New Global Journey in the AI Field — The Grand 2025 AI Intelligent Development Summit
Hong Kong, April 24, 2025 (GLOBE NEWSWIRE) -- On April 22, 2025, the "Towards the Light: Co-creating a New Global Journey in the AI Field — 2025 AI Intelligent Development Summit" grandly opened at the Hop Hing Hotel in Hong Kong, China. This forum focused …

BioNTech präsentiert auf der AACR-Jahrestagung 2025 klinische und präklinische Daten zu mRNA- und Immunonkologie-Fokus-Programmen
MAINZ, Deutschland, 24. April 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) wird auf der diesjährigen Jahrestagung der American Association for Cancer Research („AACR“), die vom 25. bis 30. April 2025 in Chicago, …

BioNTech to Present Clinical and Preclinical Data Across mRNA and Next-Generation Immuno-Oncology Priority Programs at AACR 2025
MAINZ, Germany, April 24, 2025 -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present data for selected assets from its diversified oncology pipeline, including mRNA cancer immunotherapies, next-generation immunomodulators, and targeted …

Insuranceopedia Unveils PolicyAI - Worlds First AI-Tool That Slashes Auto Insurance Costs
DELAWARE, Del., April 24, 2025 (GLOBE NEWSWIRE) -- Today, Insuranceopedia officially launches PolicyAI, a groundbreaking free tool that uses artificial intelligence to analyze auto insurance policies, identify coverage gaps, and provide personalized …

Mimecast Announces Human Risk Command Center to Provide Unprecedented Visibility and Risk Mitigation for Organizations
LEXINGTON, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Mimecast, a global cybersecurity leader transforming the way businesses manage and secure human risk, today unveiled the first-of-its-kind Human Risk Command Center. This innovative addition to Mimecast’ …